Delaware Makes Drug Prices More Transparent
Published by Delaware Public Radio
A new law eliminates the so-called gag clause making it easier for pharmacists to tell patients in Delaware about the lowest prices for their prescriptions.
WBOC reports that the clauses could be used to keep patients from knowing about the cheaper medications.
Governor John Carney signed the legislation yesterday.
He said that he is trying to make the cost of medications for Delawareans more transparent with access to direct and clear information.
He added that includes the prices of prescription drugs.
Click here to see the original article on the Delaware Public Radio website.
Recent Posts
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
-
More than half of LTC pharmacies may close unless Congress takes action, group says
Up to 60% of long-term care pharmacies may have to close if Congress doesn’t intercede by January, according to a report released Wednesday by the Senior Care Pharmacy Coalition.
-
New SCPC Member Survey Shows More than Half of America’s LTC Pharmacies May Close Locations Without Congressional Action
The Senior Care Pharmacy Coalition, the leading national voice for the long-term care (LTC) pharmacy community which provides essential and legally required services for millions of seniors in nursing homes and assisted living facilities across the country, today released the results of a new member impact survey on the unintended consequences of Medicare Part D price negotiation policies included in the Inflation Reduction Act.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.